PMID- 22516988 OWN - NLM STAT- MEDLINE DCOM- 20130628 LR - 20171116 IS - 1671-167X (Print) IS - 1671-167X (Linking) VI - 44 IP - 2 DP - 2012 Apr 18 TI - [Measurement and clinical significance of serum monocyte chemoattractant protein-1 in patients with polymyosits/dermatomyosits]. PG - 204-8 AB - OBJECTIVE: To analyze the correlated clinical significance by testing the serum monocyte chemoattractant protein-1 (MCP-1) levels of patients with polymyositis/dermatomyositis (PM/DM). METHODS: The sera from 100 adult PM/DM patients, 20 patients with pulmonary infection and 42 healthy controls were selected. The serum MCP-1 concentrations were detected by enzyme-linked immunosorbent assay (ELISA). The correlations between serum MCP-1 levels and clinical features or laboratory examinations of PM/DM patients were investigated. RESULTS: The serum levels of MCP-1 were (1 869 +/-1 590) ng/L, (1 349+/-1 303) ng/L, (493+/-255) ng/L and (256+/-144) ng/L in PM/DM patients with interstitial lung disease (ILD) and without ILD, patients with infectious lung disease and healthy controls, respectively. Serum MCP-1 levels in the PM/DM patients with ILD were significantly higher than those of the PM/DM patients without ILD, patients with infectious lung disease and healthy controls (all P values<0.01). Significant correlations were found between the elevated levels of serum MCP-1 and the presence of ILD in the patients with PM/DM (chi2=9.6, P<0.01). The sensitivity and specificity of serum abnormal MCP-1 levels for ILD in the patients with PM/DM were 60.7% and 68.2%, respectively. The incidence of fever, arthritis, decreased %DL(CO) , erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) and serum ferritin were significantly higher in the MCP-1 raised group than in the MCP-1 normal group (all P values<0.005). Additionally, Spearman rank correlation analysis showed that serum MCP-1 levels were positively correlated with serum ferritin in peripheral blood in the patients with PM/DM. CONCLUSION: The levels of serum MCP-1 are significantly elevated in PM/DM and it is significantly associated with ILD complication, and may contribute to the early differentiation of ILD from lung infectious disease. FAU - Chen, Fang AU - Chen F AD - Department of Rheumatology, China-Japan Friendship Hospital, Beijing 100029, China. FAU - Shu, Xiao-ming AU - Shu XM FAU - Wang, Dong-xue AU - Wang DX FAU - Wang, Guo-chun AU - Wang GC FAU - Lu, Xin AU - Lu X LA - chi PT - English Abstract PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - China TA - Beijing Da Xue Xue Bao Yi Xue Ban JT - Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences JID - 101125284 RN - 0 (Chemokine CCL2) SB - IM MH - Adolescent MH - Adult MH - Aged MH - Aged, 80 and over MH - Chemokine CCL2/*blood MH - Dermatomyositis/*blood/complications MH - Diagnosis, Differential MH - Female MH - Humans MH - Lung Diseases, Interstitial/diagnosis/*etiology MH - Male MH - Middle Aged MH - Pneumonia/diagnosis MH - Polymyositis/*blood/complications MH - Young Adult EDAT- 2012/04/21 06:00 MHDA- 2013/07/03 06:00 CRDT- 2012/04/21 06:00 PHST- 2012/04/21 06:00 [entrez] PHST- 2012/04/21 06:00 [pubmed] PHST- 2013/07/03 06:00 [medline] PST - ppublish SO - Beijing Da Xue Xue Bao Yi Xue Ban. 2012 Apr 18;44(2):204-8.